Tahithromos’s WisdomTree Europe Hedged Equity Fund HEDJ Stock Holding History

Tahithromos’s Portfolio HEDJ Stock Details HEDJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-128,000	Closed	-$4.23M	–	25
2015 Q1	$4.23M	Buy	+128,000	New	+$3.97M	1.96%	17

Other funds holding HEDJ

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

RIG

RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Tahithromos's HEDJ Position: Q2 2015 in Review

Tahithromos sold out of WisdomTree Europe Hedged Equity Fund (HEDJ) in Q2 2015, closing a stake of 128,000 shares — an estimated $4.23M sold.

Tahithromos first reported a position in HEDJ in Q1 2015 and held it in 1 quarter. The position peaked at $4.23M in Q1 2015. 381 funds tracked by Wall St. Rank hold HEDJ as of Q2 2015.

Tahithromos reported no remaining WisdomTree Europe Hedged Equity Fund position as of Q2 2015 after selling out during the quarter.
Tahithromos sold 128,000 WisdomTree Europe Hedged Equity Fund shares in Q2 2015, an estimated $4.23M.
Tahithromos first reported a position in WisdomTree Europe Hedged Equity Fund in Q1 2015 and held it in 1 quarter.
Tahithromos's WisdomTree Europe Hedged Equity Fund position peaked at $4.23M in Q1 2015.
381 funds tracked by Wall St. Rank held WisdomTree Europe Hedged Equity Fund as of Q2 2015.

Based on Tahithromos's 13F filing for Q2 2015, filed 29 Jul 2015.